Pure Global

LIPOPROTEIN - ANVISA Registration 82444370044

Access comprehensive regulatory information for LIPOPROTEIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 82444370044 and manufactured by DIAZYME LABORATORIES, INC.. The registration is held by Enzytec Biotecnologia Ltda. with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including DIASYS DIAGNOSTIC SYSTEMS GMBH, SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
82444370044
Registration Details
ANVISA Registration Number: 82444370044
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Família Diazyme Lipoprotein (a)
Risk Class II

Registration Details

82444370044

25351125115202351

07214566000165

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Mar 27, 2023

VIGENTE

09/18/2025 19:00:01